会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Methods for targeting and killing glioma cells
    • 靶向和杀死神经胶质瘤细胞的方法
    • US07642063B2
    • 2010-01-05
    • US11132879
    • 2005-05-19
    • Tatiana I. SamoylovaHenry J. BakerNancy R. CoxLudmila P. GlobaNancy E. Morrison
    • Tatiana I. SamoylovaHenry J. BakerNancy R. CoxLudmila P. GlobaNancy E. Morrison
    • A61K38/17A61K51/00G01N33/574
    • G01N33/574G01N33/5011G01N2500/10
    • A diagnostic technique for matching anti-cancer peptide drugs to the molecular profiles of individual cancer tumors, and a method using the technique for a patient-specific treatment of tumors in mammals. This strategy matches anti-cancer peptide drugs to the molecular profiles of individual tumors, and includes the development of two banks, both of which use the same targeting peptides. Targeting peptides are identified using biopsies or other tissue materials from multiple cancer patients and placed into two banks. For a bank of probes, targeting peptides are linked to a label such as a fluorescent or a radioisotope. For a bank of drugs, targeting peptides are linked to a cytotoxic peptide to form a “targeting peptide drug”. Peptide probes are used to establish molecular profiles of individual tumors. Based on these molecular profiles, a patient-specific combination of targeting drugs from the bank of peptide drugs is prepared and the patient is treated. Any currently used cytotoxic agent that can be linked to targeting peptides may be used in place of cytotoxic peptides.
    • 将抗癌肽药物与个体癌症肿瘤的分子特征匹配的诊断技术,以及使用该技术用于哺乳动物肿瘤患者特异性治疗的方法。 这种策略将抗癌肽药物与单个肿瘤的分子谱相匹配,并且包括两个银行的发展,两个银行都使用相同的靶向肽。 使用来自多个癌症患者的活组织检查或其他组织材料鉴定靶向肽,并将其置于两个组中。 对于一组探针,靶向肽与标记如荧光或放射性同位素连接。 对于一批药物,靶向肽与细胞毒肽连接以形成“靶向肽药物”。 肽探针用于建立单个肿瘤的分子谱。 基于这些分子谱,制备来自肽药物库的靶向药物的患者特异性组合,并对患者进行治疗。 可以使用任何目前使用的可以与靶向肽连接的细胞毒性剂来代替细胞毒性肽。
    • 9. 发明授权
    • Nucleic acid vaccination for parvoviral infections
    • 核酸疫苗接种细小病毒感染
    • US06465438B1
    • 2002-10-15
    • US09171425
    • 1998-10-19
    • Joachim SchorrHenry J. BakerBruce F. Smith
    • Joachim SchorrHenry J. BakerBruce F. Smith
    • A61K4800
    • C07K14/005A61K2039/51C12N2750/14322
    • The general field of the invention is a method for nucleic acid vaccination for animals to protect them from parvoviral infection. This invention is more particularly related to the preparation and use of parvoviral DNA and its administration to dogs, cats and mink so as to induce an immune response that can protect these animals from disease caused by virulante parvovirus. Nucleic acid immunogens are designed to include the antigenic portions of the parvoviral genome which are incorporated into bacterial plasmids. These plasmids produce the desired parvoviral gene product when introduced into host cells by transfection. Host cells transfected with the parvoviral immunogen expressing plasmids produce a stream ot antigenic proteins to which the host immune system will mount a protective immune response.
    • 本发明的一般领域是用于动物的核酸疫苗接种以保护它们免受细小病毒感染的方法。 本发明更特别涉及细小病毒DNA的制备和使用及其对狗,猫和貂的施用,以便诱导可以保护这些动物免受病毒细小病毒引起的疾病的免疫应答。 核酸免疫原被设计为包括并入细菌质粒的细小病毒基因组的抗原部分。 当通过转染引入宿主细胞时,这些质粒产生所需的细小病毒基因产物。 用细小病毒免疫原表达质粒转染的宿主细胞产生抗原蛋白质的流,宿主免疫系统将对其施加保护性免疫应答。